Cell Adhesion System for Interspecies Chimeras
Summary
USPTO published patent application US20260092259A1 by inventors Jun Wu, Emily B. Ballard, and Jia Huang for a cell adhesion system enabling formation of interspecies chimeras through engineered cells expressing antigen-binding proteins or antigens with cell membrane signaling peptides. The invention facilitates generation of organs, organoids, or tissue masses from human and non-human chimeric animals for potential transplant applications.
What changed
The USPTO published application US20260092259A1 discloses a cell adhesion system for creating interspecies chimeras by engineering cells to co-express either an antigen-binding protein or an antigen with a cell membrane signaling peptide or cell membrane anchor protein. This modification enhances cell adhesion, improving the formation of chimeras combining cells from different mammalian species, including human and non-human combinations. The application covers methods for organogenesis to generate transplantable organs and tissues using these engineered populations.
This is a patent application publication, not a binding regulatory rule. No immediate compliance actions are required. Researchers, biotechnology companies, and pharmaceutical developers working on organ generation, xenotransplantation, or chimera technologies should monitor this application's prosecution status. The invention may affect R&D priorities in regenerative medicine and transplantable organ production once the patent proceeds to grant.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CELL ADHESION SYSTEM FOR INTERSPECIES CHIMERAS
Application US20260092259A1 Kind: A1 Apr 02, 2026
Inventors
Jun Wu, Emily B. Ballard, Jia Huang
Abstract
Disclosures herein are directed to populations of cells comprising one or more cell of a first mammalian species and one or more cell of a second mammalian species, such as stem cells and embryos, wherein the cells are engineered to express an either an antigen-binding protein or an antigen, wherein each are expressed with a cell membrane signaling peptide and/or a cell membrane anchor protein. The inclusion of the cell membrane signaling peptide or a cell membrane anchor protein enhances cell adhesion, enabling improved formation of interspecies chimeras, for example the generation of a human and non-human interspecies chimera. Also provided herein are methods of manufacturing the population of cells as described herein. Also provided are methods of organogenesis to generate an organ, organoid, or tissue mass comprising an interspecies chimeric animal for organ transplant, and methods of treatment using the same.
CPC Classifications
C12N 5/0697 C12N 5/0696 C12N 2513/00 C12N 2517/02 C12N 2533/50
Filing Date
2025-07-30
Application No.
19286057
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.